Browse by author
Lookup NU author(s): Dr Ioana Cosgarea
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© Copyright © 2020 Cosgarea, Griewank, Ungureanu, Tamayo and Siepmann.Deep penetrating nevi (DPN) are rare melanocytic nevi, which can exhibit atypical histological features hampering the differentiation from malignant melanoma. DPN are considered benign melanocytic lesions, but rare spread to lymph nodes and unfavorable clinical outcomes associated with borderline/atypical DPN (B-DPN) has been reported. Since no guidelines are available for DPN and B-DPN, we aimed to review the literature on DPN and B-DPN to assess the management and prognosis. We screened 3,513 references from EMBASE, Scopus and Medline databases, and included 15 studies with a total of 355 DPN patients and 48 B-DPN patients. Therapeutic interventions ranged from simple excision to wide excisions and sentinel lymph node biopsy (SLNB), with block lymph node dissection in some positive SLNB cases. Follow-up periods ranged from 3 months to 23 years during which a total of five recurrences, two in DPN and three in B-DPN group, and three metastases, in B-DPN group, were reported. While some of the included studies comprised clinical and histopathological correlation, few included genetic assessment. The present review highlights the need for prospective cohort studies applying composite measures to identify effective regimens of diagnostic workup and treatment in DPN and B-DPN.
Author(s): Cosgarea I, Griewank KG, Ungureanu L, Tamayo A, Siepmann T
Publication type: Review
Publication status: Published
Journal: Frontiers in Oncology
Year: 2020
Volume: 10
Online publication date: 20/05/2020
Acceptance date: 28/04/2020
ISSN (electronic): 2234-943X
Publisher: Frontiers Media S.A.
URL: https://doi.org/10.3389/fonc.2020.00837
DOI: 10.3389/fonc.2020.00837
